Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elanco Animal Health

    NYSE: ELAN · Real-Time Price · USD
    14.01
    0.20 (1.45%)
    At close: Jun 16, 2025, 3:59 PM
    12.54
    -10.45%
    After-hours: Jun 16, 2025, 07:56 PM EDT

    Elanco Animal Health Statistics

    Share Statistics

    Elanco Animal Health has 496.65M shares outstanding. The number of shares has increased by 0.09% in one year.

    Shares Outstanding

    n/a
    		 496.65M

    Shares Change (YoY)

    n/a
    		 0.09%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 99%

    Shares Floating

    n/a
    		 491.95M

    Failed to Deliver (FTD) Shares

    n/a
    		 58

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 26.17M, so 5.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 26.17M

    Short % of Shares Out

    n/a
    		 5.27%

    Short % of Float

    n/a
    		 7.29%

    Short Ratio (days to cover)

    n/a
    		 4.04

    Valuation Ratios

    The PE ratio is 17.7 and the forward PE ratio is 14.39. Elanco Animal Health's PEG ratio is -0.14.

    PE Ratio

    n/a
    		 17.7

    Forward PE

    n/a
    		 14.39

    PS Ratio

    n/a
    		 1.35

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 0.98

    P/FCF Ratio

    n/a
    		 15.18

    PEG Ratio

    n/a
    		 -0.14
    Financial Ratio History

    Enterprise Valuation

    Elanco Animal Health has an Enterprise Value (EV) of 9.84B.

    EV / Sales

    n/a
    		 2.22

    EV / EBITDA

    n/a
    		 6.61

    EV / EBIT

    n/a
    		 18.18

    EV / FCF

    n/a
    		 24.96

    Financial Position

    The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.71.

    Current Ratio

    n/a
    		 2.44

    Quick Ratio

    n/a
    		 1.25

    Debt / Equity

    n/a
    		 0.71

    Debt / EBITDA

    n/a
    		 2.9

    Debt / FCF

    n/a
    		 10.97

    Interest Coverage

    n/a
    		 1.07

    Financial Efficiency

    Return on Equity is 5.54% and Return on Invested Capital is 1.53%.

    Return on Equity

    n/a
    		 5.54%

    Return on Assets

    n/a
    		 2.68%

    Return on Invested Capital

    n/a
    		 1.53%

    Revenue Per Employee

    n/a
    		 $493,222.22

    Profits Per Employee

    n/a
    		 $37,555.56

    Employee Count

    n/a
    		 9,000

    Asset Turnover

    n/a
    		 0.35

    Inventory Turnover

    n/a
    		 1.61

    Taxes

    Income Tax

    n/a
    		 150M

    Effective Tax Rate

    n/a
    		 30.74%

    Stock Price Statistics

    The stock price has increased by -23.15% in the last 52 weeks. The beta is 1.68, so Elanco Animal Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.68

    52-Week Price Change

    n/a
    		 -23.15%

    50-Day Moving Average

    n/a
    		 11.4

    200-Day Moving Average

    n/a
    		 12.27

    Relative Strength Index (RSI)

    n/a
    		 67.23

    Average Volume (20 Days)

    n/a
    		 5,938,312

    Income Statement

    In the last 12 months, Elanco Animal Health had revenue of 4.44B and earned 338M in profits. Earnings per share was 0.68.

    Revenue

    n/a
    		 4.44B

    Gross Profit

    n/a
    		 1.91B

    Operating Income

    n/a
    		 251M

    Net Income

    n/a
    		 338M

    EBITDA

    n/a
    		 1.49B

    EBIT

    n/a
    		 723M

    Earnings Per Share (EPS)

    n/a
    		 0.68
    Full Income Statement

    Balance Sheet

    The company has 468M in cash and 4.32B in debt, giving a net cash position of -3.85B.

    Cash & Cash Equivalents

    n/a
    		 468M

    Total Debt

    n/a
    		 4.32B

    Net Cash

    n/a
    		 -3.85B

    Retained Earnings

    n/a
    		 -1.95B

    Total Assets

    n/a
    		 12.94B

    Working Capital

    n/a
    		 2.17B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 541M and capital expenditures -147M, giving a free cash flow of 394M.

    Operating Cash Flow

    n/a
    		 541M

    Capital Expenditures

    n/a
    		 -147M

    Free Cash Flow

    n/a
    		 394M

    FCF Per Share

    n/a
    		 0.8
    Full Cash Flow Statement

    Margins

    Gross margin is 43.01%, with operating and profit margins of 5.65% and 7.61%.

    Gross Margin

    n/a
    		 43.01%

    Operating Margin

    n/a
    		 5.65%

    Pretax Margin

    n/a
    		 10.99%

    Profit Margin

    n/a
    		 7.61%

    EBITDA Margin

    n/a
    		 33.54%

    EBIT Margin

    n/a
    		 5.65%

    FCF Margin

    n/a
    		 8.88%

    Dividends & Yields

    ELAN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 5.65%

    FCF Yield

    n/a
    		 6.59%
    Dividend Details

    Analyst Forecast

    The average price target for ELAN is $15, which is 7.1% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 7.1%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 13.78

    Graham Upside

    n/a
    		 -1.64%

    Scores

    Altman Z-Score

    n/a
    		 0.94

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist